They’re really stretching out the ASM, reinforcing the conjecture that they are waiting on something significant enough to push the ASM this far out.
I don’t mind waiting for a meaningful ASM rather than a no news walk through ASM at this point, given the positive trial outcome, manufacturing, and positive approval anticipation and support in the UK.